Prevention of recurrence of atypical hemolytic uremic syndrome post renal transplant with the use of higher-dose eculizumabâ©.

Riddell, Amy; Goodship, Tim; Bingham, Coralie

Prevention of recurrence of atypical hemolytic uremic syndrome post renal transplant with the use of higher-dose eculizumabâ©.

Riddell, Amy; Goodship, Tim; Bingham, Coralie.

Clin Nephrol ; 86(10): 200-2, 2016 Oct.

Article in En | MEDLINE | ID: mdl-27616760

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Atypical Hemolytic Uremic Syndrome/prevention & control; Kidney Transplantation/adverse effects; Adult; Atypical Hemolytic Uremic Syndrome/etiology; Complement C3/antagonists & inhibitors; Complement C5/antagonists & inhibitors; Complement System Proteins; Drug Monitoring/methods; Humans; Male; Recurrence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Antibodies, Monoclonal, Humanized / Atypical Hemolytic Uremic Syndrome Type of study: Etiology_studies Limits: Adult / Humans / Male Language: En Journal: Clin Nephrol Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google